ALLERRPRO Eye Drops

Olopatadine is a potent selective antiallergic/antihistaminic agent that exerts its effects through multiple distinct mechanisms of action. It antagonises histamine (the primary mediator of allergic response in humans) and prevents histamine induced inflammatory cytokine production by human conjunctival epithelial cells. Data from in vitro studies suggest that it may act on human conjunctival mast cells to inhibit the release of pro-inflammatory mediators.

In patients with patent nasolacrimal ducts, topical ocular administration of ALLER PRO was suggested to reduce the nasal signs and symptoms that frequently accompany seasonal allergic conjunctivitis. It does not produce a clinically significant change in pupil diameter.

Indication:

Treatment of ocular signs and symptoms of seasonal allergic conjunctivitis.

Warning:

Olopatadine is an antiallergic/antihistaminic agent and, although administered topically, is absorbed systemically. If signs of serious reactions or hypersensitivity occur, discontinue the use of this treatment. Olopatadine contains Cetrimide.

Precaution:

Cetrimide has also been reported to cause punctate keratopathy and/or toxic ulcerative keratopathy. Close monitoring is required with frequent or prolonged use in dry eye patients, or in conditions where the cornea is compromised.

Cetrimide is known to discolour soft contact lenses. Avoid contact with soft contact lenses.

Patients should be instructed to remove contact lenses prior to administration of the eye drop and wait at least 15 minutes after instillation before re-inserting contact lenses.

Dosage:

The dose is one drop of Olopatadine in the conjunctival sac of the affected eye(s) twice daily (8 hourly). Treatment may be maintained for up to four months, if considered necessary.

No dosage adjustment in elderly patients is necessary.

Presentation: Available in 5 ml plastic bottle.

Storage: Store protected from light and moisture, at a temperature between 4° to 25°.

Keep the medicine out of the reach of Children.

DO NOT FREEZE.

Use the solution within one month after opening the container. If the solution becomes cloudy or dark brown, it should be discarded.

NOT FOR INJECTION

FOR OPHTHALMIC USE ONLY